Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marco Vismarra"'
Autor:
Mario Martinotti, Fernando Cirillo, Marco Ungari, Giulia Tanzi, Giovanni Rolando, Antonio Tarasconi, Valerio Ranieri, Paolo Aulisa, Marco Vismarra, Massimo Rovatti, Monica Trombatore
Publikováno v:
Rare Tumors, Vol 9, Iss 1 (2017)
Medullary carcinoma (MC) of the large intestine is a relatively new histological type of adenocarcinoma characterized by poor glandular differentiation and an intraepithelial lymphocytic infiltrate. MC can be associated to a defective mechanism for D
Externí odkaz:
https://doaj.org/article/de659527eec34f138491a8cc7ab3a6ab
Publikováno v:
Gastrointestinal endoscopy. 94(3)
Autor:
Monica Trombatore, Marco Ungari, Marco Vismarra, Massimo Rovatti, Fernando Cirillo, Antonio Tarasconi, Paolo Aulisa, Giulia Tanzi, Giovanni Rolando, Valerio Ranieri, Mario Martinotti
Publikováno v:
Rare Tumors
Rare Tumors, Vol 9, Iss 1 (2017)
Rare Tumors, Vol 9, Iss 1 (2017)
Medullary carcinoma (MC) of the large intestine is a relatively new histological type of adenocarcinoma characterized by poor glandular differentiation and an intraepithelial lymphocytic infiltrate. MC can be associated to a defective mechanism for D
Publikováno v:
Journal of Oncology, Vol 2012 (2012)
Journal of Oncology
Journal of Oncology
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Fourty-eight patients with MCC were observed at the Rare Hormonal Tumors Group of Cremona Hospital, 15 of these with unknown primary site. Due to rarity of Merkel
Autor:
Fernando, Cirillo, Marco, Vismarra, Massimo, Buononato, Enzo, Magnani, Federica, Vergoni, Mario, Martinotti
Publikováno v:
Chirurgia italiana. 60(4)
Endometriosis is a non-cancerous disorder characterised by development of endometrial epithelium outside the uterus, in which involvement of the gastrointestinal tract is most common. The most frequent site is the rectosigmoid colon (72%), whereas th
Autor:
Rossana Poli, Stefano Panni, Chiara Colombi, Roberto Delfrate, Alessandra Curti, Bruno Perrucci, Gianluca Tomasello, Wanda Liguigli, Mariangela Maltese, Federica Negri, Maddalena Donini, Rodolfo Passalacqua, Silvia Lazzarelli, Matteo Brighenti, Marco Vismarra, Margherita Ratti, Laura Toppo
Publikováno v:
Journal of Clinical Oncology. 31:4112-4112
4112 Background: TCF is a standard first line option for GEC. The Norton-Simon hypothesis suggests that chemotherapy efficacy can be enhanced by decreasing intervals between cycles. We previously reported on the high activity of TCF-dd in GEC (Tomase